Insights and Analysis

These Are The Top Priorities & Challenges For New CDER Director Patrizia Cavazzoni, M.D.

30 July 2021

Partner Lynn Mehler and Counsel Lowell Zeta pen a guest column for Life Sciences Connect where they discuss the recent appointment of a new Center for Drug Evaluation and Research director and what this will mean for evolving FDA’s regulatory programs and drug review policies.

Click here to read the full article.